Join to View Full Profile
10 Center DriveBethesda, MD 20814
Dr. Al Harthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Rochester General HospitalResidency, Internal Medicine, 2013 - 2016
Weill Cornell Medical College in QatarClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow National Institutes of Health, 2017-2019
Publications & Presentations
PubMed
- 7 citationsCabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.Ravi A. Madan, Fatima Karzai, Munjid Al Harthy, Daniel P. Petrylak, Joseph Kim
BJU International. 2021-04-01 - 14 citationsClinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer.Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Munjid Al-Harthy, Marijo Bilusic
Journal for Immunotherapy of Cancer. 2021-03-01 - 6 citationsThe changing landscape of systemic therapy in metastatic renal cell carcinoma: an update.Sandeep Gurram, Munjid Al Harthy, Mark W. Ball
Discovery Medicine. 2020-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
